Sophie Chen
May 6, 2013

J&J India needs decisive response to safety concerns: Branding consultant

MUMBAI - Johnson & Johnson, the multinational manufacturer of pharmaceutical and consumer packaged goods, lost its license to make cosmetics at a plant outside Mumbai last week, but has made no response beyond a simple statement.

J&J India needs decisive response to safety concerns: Branding consultant

India's Food and Drug Administration (FDA) cancelled the plant's licence, effective 24 June, after 15 batches of baby powder products were found to have been sterilised by ethylene oxide, an irritant and cancer-causing component, through an unauthorised process.

Johnson & Johnson did not respond to Campaign Asia-Pacific's requests for comment.

Peggy Ballman, a J&J spokeswoman, said in a statement that the company is currently working with Indian regulators to resolve the issue. In the statement, the company said the sterilisation process in question, which was not registered with the local FDA, was used as an alternative on a one-time basis on a limited amount of baby powder. It gave no explanation why the alternative process was used.

“Within India, J&J has enjoyed equity that is unassailable and there is a degree of blind trust among young mothers when it comes to products with that label tag,” said Harish Bijoor, brand strategy specialist and CEO of Harish Bijoor Consults. “An event such as this is bound to rattle that trust.”

Bijoor said the impact of such an incident will not only be on this brand, but also every brand that uses ethylene oxide at large. “The consumer is quite irrational when it comes to issues such as these,” he said. “It’s important for the company to get very active and manage the crisis with transparency and consumer clarity.”

He suggested that J&J could publish a white paper on the issue, indicating clear references of the ethylene oxide residue, as well as issue an advisory and recall all batches that have hit the market.

“What is needed is a purge of all stock that can reach consumer homes,” he said. “And the next step would be to replace ethylene oxide as a sterilisation agent altogether. Ethylene oxide is now a bad word, in terms of consumer perception. One cannot risk its continued use in manufacture anymore.”

Last month, J&J launched its first corporate branding campaign in more than 10 years, "For all you love," focusing on the lasting family values. The New York Times noted that the campaign can be seen as J&J’s attempt to shore up its brand image after several quality-control problems in the past few years, including recalls of over-the-counter medications like Motrin, children’s Tylenol liquid and Benadryl.

Source:
Campaign Asia

Related Articles

Just Published

11 hours ago

40 Under 40 2023: Ruchika Gupta, Beam Suntory

An ambassador of female leadership, Gupta is building a team of thought leaders at Beam Suntory and inspiring them to achieve their highest potential.

11 hours ago

Why does such a lack of transparency still exist in ...

Although many adtech players remain incentivised to keep the ecosystem opaque, new business models and auditing practices are challenging the status quo to demonstrate value for clients.

12 hours ago

Swatch switches media duties to Publicis from ...

Swatch is the second long-term client after Dyson to depart from GroupM to Publicis this year, following news of a bribery scandal in China in 2023.

12 hours ago

The Scott Calorie Absorber Pro converts a kitchen ...

The clever campaign reimagines the humble drying towel as a mighty health supplement in a bid to tackle Malaysia's growing obesity epidemic.